Targeting Human Telomerase by Antisense Oligonucleotides and Ribozymes: An Update

ISSN： 1567-2034

Source： Medicinal Chemistry Reviews - Online, Vol.1, Iss.4, 2004-10, pp. : 413-417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Expression of Anti-Apoptotic Proteins by Antisense Oligonucleotides

Current Drug Targets, Vol. 2, Iss. 2, 2001-06 ,pp. : 167-180

Bentham Science Publishers

Access to resources Recommend Favorite

Chemosensitization by Antisense Oligonucleotides Targeting MDM2

Current Cancer Drug Targets, Vol. 5, Iss. 1, 2005-01 ,pp. : 51-56

Bentham Science Publishers

Access to resources Recommend Favorite

Oligonucleotides and G-quadruplex Stabilizers: Targeting Telomeres and Telomerase in Cancer Therapy

Current Pharmaceutical Design, Vol. 20, Iss. 41, 2014-12 ,pp. : 6422-6437

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Telomerase by Antisense-Based Approaches: Perspectives for New Anti-Cancer Therapies

Current Pharmaceutical Design, Vol. 11, Iss. 9, 2005-04 ,pp. : 1105-1117

Bentham Science Publishers

Access to resources Recommend Favorite

Antisense and therapeutic oligonucleotides: toward a gene-targeting cancer clinic

By Cho-Chung Y.S.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 11, 2000-11 ,pp. : 1711-1724

Informa Healthcare

Access to resources Recommend Favorite